WO2020073981A1 - Valve stent and prosthetic heart valve - Google Patents

Valve stent and prosthetic heart valve Download PDF

Info

Publication number
WO2020073981A1
WO2020073981A1 PCT/CN2019/110538 CN2019110538W WO2020073981A1 WO 2020073981 A1 WO2020073981 A1 WO 2020073981A1 CN 2019110538 W CN2019110538 W CN 2019110538W WO 2020073981 A1 WO2020073981 A1 WO 2020073981A1
Authority
WO
WIPO (PCT)
Prior art keywords
valve
stent
flange
ear
valve stent
Prior art date
Application number
PCT/CN2019/110538
Other languages
French (fr)
Chinese (zh)
Inventor
阳明
冒鹏志
陈国明
赵婧
李�雨
Original Assignee
上海微创心通医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 上海微创心通医疗科技有限公司 filed Critical 上海微创心通医疗科技有限公司
Publication of WO2020073981A1 publication Critical patent/WO2020073981A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2454Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
    • A61F2/2457Chordae tendineae prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2466Delivery devices therefor

Definitions

  • the present invention relates to the technical field of medical devices, in particular to a valve stent and a prosthetic heart valve.
  • Mitral valve disease is a relatively common clinical heart valve disease.
  • the human heart is divided into four chambers: the left atrium, the left ventricle and the right atrium, and the right ventricle.
  • the two atria are connected to the two ventricles, and the two ventricles are connected to the two large arteries.
  • the mitral valve grows between the left atrium and the left ventricle, and consists of valve leaflets, annulus, chordae, and papillary muscles. It acts as a one-way valve to ensure one-way movement of blood flow.
  • the area of the artificial valve leaflet is proportional to the height required for the opening and closing movement of the valve leaflet, that is, the larger the area of the artificial valve leaflet
  • most of the artificial valve stents at home and abroad mostly use internal and external double-layer stents to reduce the diameter of the valve stent, thereby reducing the height of the valve stent, but the double-layer stent greatly increases the pressure of the stent. Difficulty.
  • the object of the present invention is to provide a valve stent and a prosthetic heart valve, in order to solve the existing artificial valve stent due to the high height of the left ventricle outflow tract obstruction and other adverse surgery After effects, due to the large leaflet area, the stent has poor fatigue resistance, and the difficulty of delivery due to the large size of the stent and the damage to the blood vessel and left ventricle.
  • a valve stent comprising a stent body arranged in a grid, at least one grab ear connected to the stent body and a flange, the outer diameter D of the flange It is larger than the diameter d where the flange is connected to the bracket body, and the size of the gripping ear is smaller than the grid size of the bracket body connected to the gripping ear.
  • the diameter range of the upper end or the lower end of the stent body is 20 mm 50 mm.
  • the outer diameter of the flange is in the range of 30mm ⁇ EK80mm.
  • one end of the grasping ear is fixed on the stent body, and the other end is radially outwardly warped.
  • the grasping ear is a straight rod or a curved wave rod.
  • a texture structure is provided on the grasping ear.
  • the grasping ear is connected to the mesh node of the stent body, or to the mesh edge bar of the stent body. [0018] Further, in the above valve stent, the grasping ear is located on the lower end grid of the stent body.
  • the free end of the flange is provided with at least one fixing ear, and the fixing ear is used to cooperate with the groove of the delivery device.
  • the fixed ear is a convex round block or square.
  • the flange is connected at a set height position of the stent body.
  • the stent body is arranged in a grid shape instead of the stent body in a round shape or diamond shape.
  • a prosthetic heart valve including a valve support, a valve leaflet fixed to the valve support, and a skirt attached to the inner or outer surface of the valve support.
  • the grid of the stent body connected to the grasping ear is provided with the skirt on the inner surface.
  • a valve stent provided by an embodiment of the present invention includes a stent body arranged in a grid, at least one grab ear and a flange connected to the stent body.
  • the grasping ear is used to grasp the native leaflet
  • the flange is used to tightly adhere to the left atrium opening and native leaflet when the valve stent is deployed.
  • the outer diameter D of the flange of the embodiment of the present invention is larger than the diameter d of the connection between the flange and the main body of the bracket, so that the horizontal plane under the flange closely fits the heart's native annulus and valve leaflets, and the upturned end surface closely
  • the inner wall of the left atrium serves as an upper limit and seal to prevent the valve stent from sliding out to the left ventricular end.
  • the grasping ear when the valve stent is compressed into the sheath, the grasping ear is embedded in the grid of the stent body connected to the grasping ear to reduce the thickness of the stent after the compression and reduction of the diameter of the valve stent, which is beneficial to the valve stent
  • the venous path intervenes in the human body, thereby reducing the diameter of the conveyor catheter, reducing the difficulty of delivery and damaging the blood vessels.
  • the grasping ears according to the embodiments of the present invention grab the native valve leaflets while hooking the tendon cord to form a lower limit, which prevents the valve stent from being pulled out to the left atrium end due to external forces such as blood flow washing and heart compression.
  • FIG. 1 is a front view of a prosthetic heart valve stent according to an embodiment of the present invention
  • FIG. 2 is a top view of a prosthetic heart valve stent according to an embodiment of the present invention.
  • FIG. 3 is a schematic structural view of an embodiment of the present invention.
  • FIG. 4 is a top view of a stent structure according to an embodiment of the present invention.
  • FIG. 5 is a front view of a diamond ring flange according to an embodiment of the present invention.
  • FIG. 6 is a plan view of a diamond ring flange according to an embodiment of the present invention.
  • FIG. 7 is a schematic diagram of a connection relationship between a flange and a bracket body according to an embodiment of the present invention.
  • FIG. 8 is a schematic diagram of a straight bar grab ear according to an embodiment of the present invention.
  • FIG. 9 is a schematic diagram of an ear grip of an embodiment of the present invention.
  • FIG. 10 is a schematic view of the cutting ear and the main body of the bracket according to an embodiment of the present invention.
  • FIG. 11 is a schematic diagram of grabbing the ear leaflets and hooking the tendon according to the embodiment of the present invention.
  • FIG. 12 is a partially enlarged schematic view at the position D of FIG. 11;
  • FIG. 13 is a schematic diagram of implantation of a prosthetic heart valve stent according to an embodiment of the present invention.
  • FIG. 14 is a schematic diagram of loading a prosthetic heart valve stent according to an embodiment of the present invention.
  • the present invention provides a prosthetic heart valve, including a valve support 10, a valve leaflet 20 fixed on the valve support 10, and attached to the inner surface or outer surface of the valve support 10 The surface skirt 30.
  • the valve stent 10 of the embodiment of the present invention is mainly a support positioning member for supporting structures such as valve leaflets and skirts.
  • the valve stent 10 of the embodiment of the present invention is made of a metal material.
  • it is made of shape memory alloy.
  • the bracket 10 is formed by cutting a nickel-titanium alloy pipe.
  • valve leaflet 20 in the embodiment of the present invention is an artificial valve leaflet, which is a component used to replace the native valve leaflet for opening and closing movement and controlling the blood flow direction.
  • the skirt 30 of the embodiment of the present invention is made of biological material, specifically, it can be made of polyethylene terephthalate PET, or polytetrafluoroethylene PTFE, or animal pericardium material, It is a layer of film with functions such as anti-valvular leakage.
  • a valve stent 10 provided in an embodiment of the present invention includes a stent body 102 arranged in a grid, one end of the stent body 102 is fixedly connected to at least one grasping ear 103, and the other end Connected to flange 101.
  • the grasping ear 103 is used to grasp a native valve leaflet when the valve stent is deployed, and the flange 101 is used to closely adhere to the left atrium opening and the native valve leaflet when the valve stent is deployed.
  • the bottom end of the grip ear 103 of the embodiment of the present invention is fixed to the bracket body 102, and the top end is outwardly bent to form a vertical rod shape, and is evenly distributed on the outer surface of the bracket body 102 in the circumferential direction.
  • the grabbing ear 103 is fixed to the bracket body 102 by riveting, welding, or snapping.
  • the relative position of the gripping ear 103 and the bracket body 102 in the embodiment of the present invention is not unique.
  • the end of the bracket body 102 near the flange 101 is the upper end, and the end of the bracket body 102 away from the flange 101 is the lower end.
  • the lower grid of the bracket body 102 is the bottommost grid of the bracket body 102.
  • the grasping ear 103 may be located on the lower end grid of the stent body 102, so that the grasping ear 103 better grasps the tendon 202 while grasping the native valve leaflet 201 to form a lower limit.
  • the gripping ears 103 can also be located on the remaining rows of grids of the bracket body 102.
  • the specific position of the grasping ear 103 can be adjusted appropriately according to the actual heart anatomy and the structural design of the stent body 102.
  • each grasping ear 103 in the embodiment of the present invention is not fixed, preferably, six grasping ears 103 are provided, and in implementation, each grasping ear 103 may be located on the same row of grids of the bracket body 102, or They are alternately located on different rows of grids of the bracket body 102, and can be connected to the grid nodes of the bracket body 102, and can also be connected to the grid edge bars of the bracket body 102.
  • the row of grids described herein refers to a group of grids arranged along the circumference of the bracket body 102.
  • the overall size of the grasping ear 103 of the embodiment of the present invention is smaller than the size of the mesh of the stent body 102 connected to the grasping ear 103, so that when the valve stent is compressed and contracted into the delivery catheter, the grasping ear 103 can be embedded into In the mesh space of the stent body 102 connected to it, to reduce the thickness of the stent after the compression and reduction of the diameter of the valve stent, it is helpful for the valve stent to intervene in the human body through the femoral vein path, thereby reducing the diameter of the conveyor catheter and reducing the difficulty of delivery and Damage to blood vessels.
  • the mesh connected to the gripping ear 103 can only sew the skirt on the inner surface, but cannot sew the skirt on the outer surface. Otherwise, stitching the outer skirt will prevent the gripping ear 103 from being embedded in the connected mesh.
  • the grip ear 103 of the embodiment of the present invention has various shapes, which may be a straight rod (as shown in FIG. 8) or a slightly curved wave rod (as shown in FIG. 9) to increase the grip The grasping force of the ear 103 on the native leaflet, to And improve its hooking performance to tendon.
  • all of the above shapes of the grasping ear 103 need to meet the requirement that “the grasping ear 103 can be embedded in the mesh connected to it when the stent is compressed and contracted into the delivery catheter.
  • the surface of the gripping ear 103 in this embodiment of the present invention may be a smooth surface or a rough surface.
  • the grasping ear 103 is provided with a texture structure.
  • the texture structure may be set as a regular texture structure or an irregular texture structure to increase the friction between the grasping ear and the valve leaflets and tendon cords.
  • the cardiac native leaflet cycle repeats the opening and closing movement, and the grasping ear 103 grabs the free end of the native valve leaflet 201 that is undergoing the closing movement.
  • the native valve leaf 201 will not be able to perform the opening movement, and the native valve leaf 201 closely adheres to the outer surface of the stent body 102 to achieve the sealing effect and prevent the occurrence of paravalvular leakage.
  • the grasping ear 103 of the embodiment of the present invention grabs the native valve leaf 201 and hooks the tendon 202 to form a lower limit (see the position of FIG.
  • the embodiments of the present invention do not require large-scale design to obtain support like some conventional brackets, thereby ensuring the realization of a smaller diameter of the bracket body 102.
  • the stent body 102 of the embodiment of the present invention has a small diameter, and the upper and lower ends have a diameter ranging from 20mm to 50mm.
  • the stent body 102 of the present invention can be made into a cylindrical shape with the same diameter at the upper and lower ends.
  • the bracket body 102 is formed in an inverted trapezoid shape with an upper width and a narrow width or a trapezoid shape with an upper width and a lower width, or even a bucket shape with a convex middle portion with the same diameter at the upper and lower ends.
  • a shape with a narrower lower end is preferred, because under the condition of ensuring the normal operation of the artificial valve stent, the narrower the lower end of the valve stent, the less the interference with the aorta.
  • the embodiments of the present invention may attach the skirt 30 to the inner surface or the outer surface or both sides of the stent body 102 by means of stitching, adhesion, etc.
  • the interior of the stent body 102 also passes Sutures, adhesions, etc. carry artificial leaflets.
  • the form and shape of the stent body 102 in the embodiments of the present invention are various.
  • the contour of the stent body 102 can be changed to a trapezoid, an inverted trapezoid, etc. according to the heart anatomy. form.
  • the grid shape of the bracket body 102 may also be various suitable shapes such as a circle and a diamond shape. The shape and size of the grid may be uniform or non-uniform.
  • the flexible setting of the stent body 102 can be achieved through various forms such as materials, processes, and structures.
  • the stent body 102 is precisely attached to the native heart valve leaflet in the circumferential direction Close, play a sealing role.
  • the diameter of the stent body 102 is small, and the space required for the leaflet to perform the opening and closing movement is small. Accordingly, the area of the artificial leaflet is reduced, and the fatigue resistance of the valve stent is improved.
  • the embodiment of the present invention does not affect the normal function of the heart, the upper end portion of the stent body 102 at the left atrium end protrudes an appropriate height, can be part of the artificial valve leaf opening and closing height required to distribute to the left atrium End, thereby reducing the height of the subvalvular, can also reduce the impact of the valve stent on the aortic valve, and reduce the risk of left ventricular outflow tract obstruction.
  • the outer diameter D of the flange 101 is larger than the diameter d of the connection between the flange 101 and the stent body 102, so that the flange 101 is tightly attached to the heart annulus and valve
  • the leaf, the edge upturned end surface is close to the inner wall of the left atrium, and serves as an upper limit and a seal to prevent the valve stent from sliding out to the left ventricular end.
  • the outer diameter D at the edge of the flange 101 of the present invention is the maximum diameter of the flange, 30mm ⁇ D ⁇ 80mm; the diameter d of the connection between the flange 101 and the bracket body 102 is The minimum diameter of the flange 101 is 20mmSd ⁇ 50mm.
  • the minimum diameter of the flange 101 is the diameter at the upper end of the bracket body 102.
  • the diameter of the connection between 101 and the main body 102 of the stent is not necessarily equal. If they are not equal, you can fill the gap between the two by connecting the skirt, pericardium and other connecting objects. According to different design and usage requirements, the present invention can also attach the skirt 30 to the inner surface or outer surface of the flange 101 or both sides by means of stitching, adhesion and the like.
  • the flange 101 of the embodiment of the present invention is connected to the set height position of the bracket body 102.
  • the upper end of the bracket body 102 in the embodiment of the present invention can properly cross the lower plane of the flange 101, that is, the connection point between the flange 101 and the bracket body 102 is not necessarily an end, and the flange 101 can also be connected to the bracket body 102 Any suitable height position, that is, after the valve stent is implanted into the heart, the stent body 102 is partially exposed in the left atrium, which reduces the height of the valve stent below the left ventricle and reduces the valve stent's ejection of the aorta influences.
  • the embodiments of the present invention can also ensure that the stent body 102 and the flange 101 do not overlap with each other when the diameter of the stent body 102 and the flange 101 are compressed by the means such as optimized structural design, which increases the thickness of the valve stent after the crush .
  • the flange 101 of the present invention is made of a flexible material.
  • the flexible setting of the flange 101 can be achieved through various forms of materials, processes, structures, etc., to ensure that the wide flange can be compressed and shrunk into the sheath .
  • the grasping ear 103 will be subjected to the force of the native tissue toward the left ventricle when grasping the valve leaflet and hooking the tendon, because the grasping ear 103 is connected to the stent body 102, As a result, the entire stent 10 will be affected by this force and tend to move toward the left ventricle.
  • the flange 101 closely fits the native annulus and leaflet of the heart (see Figure 13-A At the end), the edge upturned end surface is closely attached to the inner wall of the left atrium (see position in Figure 13-B), which acts as an upper limit and seals to prevent the valve stent 10 from sliding out to the left ventricular end.
  • the flange 101 of the present invention is relatively wide, which can enhance the sealing performance of the valve stent 10 in the left atrium, and is more conducive to preventing the occurrence of paravalvular leakage.
  • the positioning, anchoring and sealing of the stent according to the embodiment of the present invention is achieved by the upper limit of the flange 101, the lower limit of the grasping ear 103, and the grasping of the leaflet by the grasping ear 103, while some traditional stents rely on oversize It is designed to obtain the radial support force to be supported at the native petal, and the structural rigidity required by the stent is strong. Therefore, in contrast, the flexible arrangement of the stent in the embodiment of the present invention is more advantageous for the valve stent to intervene in the human body through the femoral vein path, and the valve stent can be compressed and held smaller, and the diameter of the adapted delivery catheter is smaller. Reduced the difficulty of delivery and damage to blood vessels. Further, there are various manufacturing methods of the flange 101 in the embodiment of the present invention, and the present invention provides the following manufacturing methods:
  • the flange 101 and the bracket body 102 are produced by cutting together. Specifically, the metal tube, such as a nickel-titanium alloy pipe, is cut by laser, and the flange 101 and the bracket body 102 are simultaneously cut into the bracket prototype, and then passed The heat treatment diameter expansion qualitative process is made into the final form.
  • the metal tube such as a nickel-titanium alloy pipe
  • the flange 101 and the bracket body 102 are separately cut and manufactured. Specifically, the metal tube, such as a nickel-titanium alloy tube, is cut by laser to separate the flange 101 and the bracket body 102 into a prototype bracket, and then separately The final shape is made by the heat treatment diameter expansion qualitative process, and finally the flange 101 and the bracket body 102 are connected into one body.
  • the metal tube such as a nickel-titanium alloy tube
  • the manufacturing method of the flange 101 is not limited to the above method, and other methods that can make the flange 101 are applicable to the embodiments of the present invention.
  • the “laser cut metal pipe” in the above two production methods can also be replaced with various suitable methods such as “nickel-titanium wire braiding”, “3D printing” and the like.
  • the shape of the flange 101 of the embodiment of the present invention is diverse, in addition to the grid structure shown in the figure, the outline of the flange 101 can also be designed in the form of divergent rods, divergent branches and the like. If the flange 101 is designed as a grid
  • the shape of the grid can be various suitable shapes such as circles and diamonds (as shown in Figure 5-6).
  • the shape and size of the grid can be uniform or non-uniform.
  • the rods and rings can be connected to each other or independent of each other
  • connection method of the flange 101 of the present invention and the bracket body 102 includes, but is not limited to, one or more of the following: rope sewing, skirt connection, riveting or welding.
  • the manufacturing method of the gripping ear 103 of the present invention is not unique, for example, by cutting the pipe material by laser, the gripping ear 103 and the bracket body 102 are simultaneously cut out of the prototype of the bracket, that is, the grid gap of the gripping ear 103 needs to be provided In addition, an additional rod is cut out, and then the final shape is made by heat treatment, diameter expansion and qualitative processes.
  • the gripping ear 103 and the bracket body 102 can also be cut separately, and then the gripping ear 103 and the bracket body 102 can be connected by riveting, welding, snapping, or other suitable methods, but no matter what process, all When crimping into the delivery catheter, the grasping ear 103 can be embedded in the mesh connected to it, as shown in Figure 10
  • the free end of the flange 101 of the embodiment of the present invention is provided with at least one fixing ear 104, and the fixing ear 104 fixes the bracket and the delivery device.
  • some fixing ears 104 may be additionally designed on the upturned end of the flange 101, and the fixing ears 104 are mainly used for snapping on a structure matching it in the conveying device, so that The stent can be pulled or pushed by the delivery device.
  • the fixing ear 104 may be a protruding round block or a square, or may be a round hole cut in the support rod, and other suitable forms.
  • the number of the fixed ears 104 is at least 3, or a multiple of 3, which may be 3, 6, 9 and so on. It should be noted that the fixing ear 104 according to the embodiment of the present invention may also be designed at other suitable positions of the valve support according to different delivery device structures.
  • the tricuspid valve serves as the atrioventricular valve of the right heart, its structure is similar to the mitral valve, and also includes valve leaflets, annulus, chordae, and papillary muscles. Therefore, the heart valve stent replacing the native mitral valve in the embodiment of the present invention can also be used to replace the native tricuspid valve, and the valve stent size is different according to the native valve size.
  • a prosthetic heart valve stent delivery device which includes a sheath 401 that wraps a compression valve stent and a fixed head 402 that fixes the stent 10.
  • the groove on the fixing head 402 matches the fixing ear 104 of the bracket 10.
  • the loading of the valve stent in the embodiment of the present invention is performed in an extracorporeal ice water bath.
  • the valve holder is pressed and held in ice water below 5 ° C, and the fixing ear 104 is snapped and fixed in the groove of the fixing head 402
  • the auxiliary device such as a loading tool, controls the handle of the conveyor to gradually retract the valve stent into the sheath 401.
  • the conveyor passes through the guide wire, along the femoral vein to the position of the diseased mitral valve, and selects the appropriate release position to start the release.
  • the valve stent release process of the embodiment of the present invention includes the following stages.
  • the first stage after the control handle is withdrawn, the sheath tube 401 is released, and the grasping ear 103 is released first, and then the sheath tube 401 is removed afterwards, and a part of the stent body 102 is released. , So that the grasping ear 103 can pass through enough tendons to grasp the valve leaflet when the native mitral valve leaflet of the heart is closed.
  • the second stage push the conveyor downward, adjust the angle of the grasping ear 103, grasp the leaflets, and hook the tendon.
  • the third stage continue to withdraw the sheath tube 401, adjust the position and depth of the valve holder, adjust the relative position of the flange 101 and the native heart valve leaflet, completely release the flange 101, withdraw the conveyor, and the valve holder 10 begins to work normally
  • the present invention is based on a single-layer stent as the premise of the small-diameter stent body, compatible with the dual advantages of easy compression delivery and reducing the impact of the valve stent on the aortic valve.
  • the ear grab of the present invention has a small volume, and the grid space can be used to hold the ear during crimping, which reduces the thickness of the stent of the valve stent after crimping and shrinking, and is more conducive to the intervention of the valve stent through the femoral vein path.
  • the diameter of the conveyor catheter reduces the difficulty of delivery and damage to blood vessels.
  • the upper end of the stent body of the present invention can properly cross the lower plane of the flange and be exposed in the left atrium, thereby reducing the height of the subvalvular, mitigating the effects of papillary muscle intervention, aortic sinus interference, and left ventricular outflow tract obstruction.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

A valve stent (10) and a prosthetic heart valve. The valve stent comprises a stent body (102) provided in a grid shape, at least one catch lug (103) and a flange (101) which are connected to the stent body (102). The outer diameter D of the flange (101) is greater than the diameter d at the junction between the flange (101) and the stent body (102), so that the lower horizontal surface of the flange (101) tightly fits the heart's native valve annulus and leaflet (201), and the edge-upturned end surface thereof tightly fits the inner wall of the left atrium to achieve upper limiting and sealing functions, preventing the valve stent (10) from sliding out toward the left ventricular end. When the valve stent (10) is compressed into a sheath, the catch lug (103) is embedded into the grid of the stent body (102) connected to the catch lug (103), so as to reduce the stent thickness of the valve stent (10) after being compressed and diameter-reduced, thereby facilitating the intervention of the valve stent (10) to the human body through the femoral vein path, reducing the diameter of a transporter catheter, and reducing the difficulty of transporting and damage to blood vessels. In addition, the catch lug (103) hooks the chordae tendineae (202) while catching the native leaflet (201) to form a lower limit, preventing the valve stent (10) from escaping toward the left atrium end due to external forces such as blood flow flushing and heart compression.

Description

一种瓣膜支架及假体心脏瓣膜  Valve support and prosthetic heart valve
技术领域  Technical field
[0001] 本发明涉及医疗器械技术领域, 具体涉及一种瓣膜支架及假体心脏瓣膜。  [0001] The present invention relates to the technical field of medical devices, in particular to a valve stent and a prosthetic heart valve.
背景技术  Background technique
[0002] 随着社会经济的发展和人口老龄化的加重, 老年性瓣膜病以及冠心病、 心肌梗 死后引起的瓣膜病变也越来越常见。 研究表明, 超过 13.3%的 75岁以上的老年人 患有不同程度的瓣膜性心脏病。 心脏瓣膜疾病已逐渐成为威胁人类健康的重要 原因之一。  [0002] With the development of social economy and the aging of the population, senile valvular disease and valvular disease caused by coronary heart disease and myocardial infarction are more and more common. Studies have shown that more than 13.3% of elderly people over the age of 75 suffer from varying degrees of valvular heart disease. Heart valve disease has gradually become one of the important reasons threatening human health.
[0003] 二尖瓣疾病是临床上比较常见的心脏瓣膜疾病。 人体的心脏分为左心房、 左心 室和右心房、 右心室四个心腔, 两个心房分别和两个心室相连, 两个心室和两 个大动脉相连。 二尖瓣就生长在左心房和左心室之间, 由瓣叶、 瓣环、 腱索、 和乳头肌组成, 起到单向阀门的作用, 保证血流单方向运动。  [0003] Mitral valve disease is a relatively common clinical heart valve disease. The human heart is divided into four chambers: the left atrium, the left ventricle and the right atrium, and the right ventricle. The two atria are connected to the two ventricles, and the two ventricles are connected to the two large arteries. The mitral valve grows between the left atrium and the left ventricle, and consists of valve leaflets, annulus, chordae, and papillary muscles. It acts as a one-way valve to ensure one-way movement of blood flow.
[0004] 1984年, Inoue等首次报道了经皮二尖瓣球囊成形术治疗二尖瓣狭窄, 如今, 该方法已日趋完善, 成为介入治疗二尖瓣狭窄的重要措施。 而且, 随着近年来 经皮人工肺动脉瓣、 主动脉瓣支架植入相继进入了临床试用, 以及国外学者应 用两种不同带瓣膜支架进行经皮三尖瓣支架植入动物实验研究的成功, 预示着 介入技术在房室瓣疾病治疗领域将会产生更大的作用。  [0004] In 1984, Inoue et al. Reported for the first time that percutaneous mitral valve balloon angioplasty for the treatment of mitral stenosis. Today, this method has become increasingly sophisticated and has become an important measure for interventional treatment of mitral stenosis. Moreover, with the recent success of percutaneous prosthetic pulmonary valve and aortic valve stent implantation in clinical trials, as well as the success of foreign scholars using two different valved stents for percutaneous tricuspid valve implantation in animal experiments, it indicates that Interventional techniques will have a greater role in the treatment of atrioventricular valve diseases.
发明概述  Summary of the invention
技术问题  technical problem
[0005] 然而, 虽然二尖瓣瓣膜置换技术飞速发展, 但是在瓣膜支架的设计上仍存在一 些公认的难题。 与主动脉瓣相比, 心脏原生二尖瓣瓣环直径较大, 为了考虑防 瓣周漏性能、 支架锚固性能等因素, 人工二尖瓣瓣膜支架尺寸也会较大, 由此 便会带来一系列问题:  [0005] However, despite the rapid development of mitral valve replacement technology, there are still some recognized problems in the design of valve stents. Compared with the aortic valve, the heart's native mitral valve annulus has a larger diameter. In order to consider the performance of anti-valvular leakage and stent anchoring performance, the size of the artificial mitral valve stent will also be larger, which will bring about A series of questions:
[0006] 1、 人工瓣膜支架尺寸越大, 支架越难压握, 需要用来输送瓣膜支架的导管直 径也会很大, 增加了输送难度和对血管的损伤。  [0006] 1. The larger the size of the artificial valve stent, the more difficult it is to hold the stent. The diameter of the catheter required to deliver the valve stent will also be large, increasing the difficulty of delivery and damage to the blood vessel.
[0007] 2、 人工瓣膜支架尺寸越大, 人工瓣叶的面积也很大, 瓣叶面积越大, 人工瓣 膜支架的耐疲劳性能越差。 [0007] 2. The larger the size of the artificial valve support, the larger the area of the artificial valve leaflet, and the larger the area of the valve leaflet, the artificial valve The lower the fatigue resistance of the membrane support.
[0008] 3、 人工瓣叶的面积和瓣叶启闭运动所需的高度成正比, 即人工瓣叶面积越大 [0008] 3. The area of the artificial valve leaflet is proportional to the height required for the opening and closing movement of the valve leaflet, that is, the larger the area of the artificial valve leaflet
, 瓣膜支架高度越高。 如果人工瓣膜支架瓣下高度过高会影响原生心脏结构与 心脏功能, 发生腱索断裂, 触碰乳头肌等心脏组织异常, 同时易引起左心室流 出道阻塞, 诱发不良的术后影响。 为了降低人工瓣膜支架瓣下高度, 目前国内 外大多数人工瓣膜支架多采用内外双层支架来缩小瓣膜支架直径, 进而减小瓣 膜支架高度, 但是双层支架却又大大增加了支架压握输送的难度。 , The higher the height of the valve stent. If the height of the artificial valve stent under the valve is too high, it will affect the original heart structure and heart function, rupture of tendon cord, abnormal heart tissue such as touching the papillary muscle, and it is easy to cause obstruction of the left ventricular outflow and induce adverse postoperative effects. In order to reduce the height of the prosthetic valve stent, most of the artificial valve stents at home and abroad mostly use internal and external double-layer stents to reduce the diameter of the valve stent, thereby reducing the height of the valve stent, but the double-layer stent greatly increases the pressure of the stent. Difficulty.
问题的解决方案  Solution to the problem
技术解决方案  Technical solution
[0009] 针对上述现有技术的缺点, 本发明的目的是提供一种瓣膜支架及假体心脏瓣膜 , 以解决现有人工瓣膜支架因瓣下高度过高引起的左心室流出道阻塞等不良术 后影响, 因瓣叶面积大, 使得支架耐疲劳性能差, 以及因支架整体尺寸大而引 起的输送难度大和对血管的损伤左心室等问题。  [0009] In view of the above-mentioned shortcomings of the prior art, the object of the present invention is to provide a valve stent and a prosthetic heart valve, in order to solve the existing artificial valve stent due to the high height of the left ventricle outflow tract obstruction and other adverse surgery After effects, due to the large leaflet area, the stent has poor fatigue resistance, and the difficulty of delivery due to the large size of the stent and the damage to the blood vessel and left ventricle.
[0010] 根据本发明的一个方面, 提供了一种瓣膜支架, 包括呈网格状设置的支架主体 、 与所述支架主体连接的至少一个抓耳和法兰, 所述法兰的外径 D大于所述法兰 与所述支架主体连接处的直径 d, 所述抓耳的尺寸小于与所述抓耳相连的所述支 架主体的网格尺寸。  [0010] According to an aspect of the present invention, there is provided a valve stent, comprising a stent body arranged in a grid, at least one grab ear connected to the stent body and a flange, the outer diameter D of the flange It is larger than the diameter d where the flange is connected to the bracket body, and the size of the gripping ear is smaller than the grid size of the bracket body connected to the gripping ear.
[0011] 进一步地, 上述瓣膜支架中, 所述支架主体的上端或下端的直径的范围为 20m m_50mm。  [0011] Further, in the above valve stent, the diameter range of the upper end or the lower end of the stent body is 20 mm 50 mm.
[0012] 进一步地, 上述瓣膜支架中, 所述法兰的外径的范围为 30mm^EK80mm。  [0012] Further, in the above valve stent, the outer diameter of the flange is in the range of 30mm ^ EK80mm.
[0013] 进一步地, 上述瓣膜支架中, 所述法兰与所述支架主体连接处的直径的范围为 [0013] Further, in the above valve stent, the range of the diameter of the connection between the flange and the stent body is
20mm<d<50mm 20mm <d <50mm
[0014] 进一步地, 上述瓣膜支架中, 所述抓耳的一端固定于支架主体上, 另一端径向 外翘。  [0014] Further, in the above valve stent, one end of the grasping ear is fixed on the stent body, and the other end is radially outwardly warped.
[0015] 进一步地, 上述瓣膜支架中, 所述抓耳为直杆或弯曲的波杆。  [0015] Further, in the above valve stent, the grasping ear is a straight rod or a curved wave rod.
[0016] 进一步地, 上述瓣膜支架中, 所述抓耳上设有纹路结构。  [0016] Further, in the above-mentioned valve stent, a texture structure is provided on the grasping ear.
[0017] 进一步地, 上述瓣膜支架中, 所述抓耳与所述支架主体的网格节点相连, 或与 所述支架主体的网格边缘杆相连。 [0018] 进一步地, 上述瓣膜支架中, 所述抓耳位于所述支架主体的下端网格上。 [0017] Further, in the above-mentioned valve stent, the grasping ear is connected to the mesh node of the stent body, or to the mesh edge bar of the stent body. [0018] Further, in the above valve stent, the grasping ear is located on the lower end grid of the stent body.
[0019] 进一步地, 上述瓣膜支架中, 所述法兰的自由端部设置有至少一个固定耳, 所 述固定耳用于与输送装置的凹槽相配合。  [0019] Further, in the above valve holder, the free end of the flange is provided with at least one fixing ear, and the fixing ear is used to cooperate with the groove of the delivery device.
[0020] 进一步地, 上述瓣膜支架中, 所述固定耳为凸出的圆块或方块。  [0020] Further, in the above valve stent, the fixed ear is a convex round block or square.
[0021] 进一步地, 上述瓣膜支架中, 所述法兰连接在所述支架主体的设定高度位置。  [0021] Further, in the above valve stent, the flange is connected at a set height position of the stent body.
[0022] 进一步地, 上述瓣膜支架中, 所述支架主体呈网格状设置替换为支架主体呈圆 形状或菱形状设置。  [0022] Further, in the above valve stent, the stent body is arranged in a grid shape instead of the stent body in a round shape or diamond shape.
[0023] 根据本发明的另一个方面, 提供了一种假体心脏瓣膜, 包括瓣膜支架, 固定于 所述瓣膜支架上的瓣叶, 以及附着在瓣膜支架内表面或外表面的裙边。  [0023] According to another aspect of the present invention, there is provided a prosthetic heart valve, including a valve support, a valve leaflet fixed to the valve support, and a skirt attached to the inner or outer surface of the valve support.
[0024] 进一步地, 上述假体心脏瓣膜, 与所述抓耳相连的所述支架主体的网格在内表 面上设置所述裙边。  [0024] Further, in the above prosthetic heart valve, the grid of the stent body connected to the grasping ear is provided with the skirt on the inner surface.
[0025] 与现有技术相比, 本发明实施例提供的瓣膜支架, 包括呈网格状设置的支架主 体, 与所述支架主体连接的至少一个抓耳和法兰。 抓耳用于抓取原生瓣叶, 法 兰用于在瓣膜支架展开时紧贴左心房口和原生瓣叶。 本发明实施例所述法兰的 外径 D大于所述法兰与所述支架主体连接处的直径 d, 使得法兰下水平面紧贴合 心脏原生瓣环和瓣叶, 边缘上翘端面紧贴左心房内壁, 起到上限位和密封的作 用, 防止瓣膜支架向左心室端滑出。 本发明实施例在瓣膜支架压缩入鞘时, 所 述抓耳嵌入与抓耳相连的支架主体的网格中, 以减小瓣膜支架在压握缩径后的 支架厚度, 有利于瓣膜支架经股静脉路径介入人体, 从而减小输送器导管直径 , 降低输送难度和对血管的损伤。 此外, 本发明实施例所述抓耳在抓取原生瓣 叶的同时钩挂腱索, 形成下限位, 防止了瓣膜支架受血流冲刷、 心脏挤压等外 力而向左心房端脱出。  [0025] Compared with the prior art, a valve stent provided by an embodiment of the present invention includes a stent body arranged in a grid, at least one grab ear and a flange connected to the stent body. The grasping ear is used to grasp the native leaflet, and the flange is used to tightly adhere to the left atrium opening and native leaflet when the valve stent is deployed. The outer diameter D of the flange of the embodiment of the present invention is larger than the diameter d of the connection between the flange and the main body of the bracket, so that the horizontal plane under the flange closely fits the heart's native annulus and valve leaflets, and the upturned end surface closely The inner wall of the left atrium serves as an upper limit and seal to prevent the valve stent from sliding out to the left ventricular end. In the embodiment of the present invention, when the valve stent is compressed into the sheath, the grasping ear is embedded in the grid of the stent body connected to the grasping ear to reduce the thickness of the stent after the compression and reduction of the diameter of the valve stent, which is beneficial to the valve stent The venous path intervenes in the human body, thereby reducing the diameter of the conveyor catheter, reducing the difficulty of delivery and damaging the blood vessels. In addition, the grasping ears according to the embodiments of the present invention grab the native valve leaflets while hooking the tendon cord to form a lower limit, which prevents the valve stent from being pulled out to the left atrium end due to external forces such as blood flow washing and heart compression.
发明的有益效果  Beneficial effects of invention
对附图的简要说明  Brief description of the drawings
附图说明  BRIEF DESCRIPTION
[0026] 图 1为本发明实施例的假体心脏瓣膜支架主视图;  [0026] FIG. 1 is a front view of a prosthetic heart valve stent according to an embodiment of the present invention;
[0027] 图 2为本发明实施例的假体心脏瓣膜支架俯视图;  [0027] FIG. 2 is a top view of a prosthetic heart valve stent according to an embodiment of the present invention;
[0028] 图 3为本发明实施例支架结构示意图; [0029] 图 4为本发明实施例支架结构俯视图; [0028] FIG. 3 is a schematic structural view of an embodiment of the present invention; [0029] FIG. 4 is a top view of a stent structure according to an embodiment of the present invention;
[0030] 图 5为本发明实施例菱形环状法兰主视图;  [0030] FIG. 5 is a front view of a diamond ring flange according to an embodiment of the present invention;
[0031] 图 6为本发明实施例菱形环状法兰俯视图;  [0031] FIG. 6 is a plan view of a diamond ring flange according to an embodiment of the present invention;
[0032] 图 7为本发明实施例法兰与支架主体连接关系示意图;  [0032] FIG. 7 is a schematic diagram of a connection relationship between a flange and a bracket body according to an embodiment of the present invention;
[0033] 图 8为本发明实施例直杆抓耳示意图;  [0033] FIG. 8 is a schematic diagram of a straight bar grab ear according to an embodiment of the present invention;
[0034] 图 9为本发明实施例波杆抓耳示意图;  [0034] FIG. 9 is a schematic diagram of an ear grip of an embodiment of the present invention;
[0035] 图 10为本发明实施例抓耳和支架主体切割示意图;  [0035] FIG. 10 is a schematic view of the cutting ear and the main body of the bracket according to an embodiment of the present invention;
[0036] 图 11为本发明实施例抓耳抓取瓣叶、 钩挂腱索示意图;  [0036] FIG. 11 is a schematic diagram of grabbing the ear leaflets and hooking the tendon according to the embodiment of the present invention;
[0037] 图 12为图 11的 D位置处局部放大示意图;  [0037] FIG. 12 is a partially enlarged schematic view at the position D of FIG. 11;
[0038] 图 13为本发明实施例假体心脏瓣膜支架植入示意图;  [0038] FIG. 13 is a schematic diagram of implantation of a prosthetic heart valve stent according to an embodiment of the present invention;
[0039] 图 14为本发明实施例假体心脏瓣膜支架装载示意图;  14 is a schematic diagram of loading a prosthetic heart valve stent according to an embodiment of the present invention;
[0040] 10-支架; 20 -瓣叶; 30-裙边; 101-法兰; 102 -支架主体; 103 -抓耳; 104 -固定 耳; 201 -原生瓣叶; 202 -腱索; 301 -左心房; 302 -左心室; 401-鞘管; 402 -固定 头。  [0040] 10-stent; 20-valve; 30-skirt; 101-flange; 102-stent body; 103-grasping ear; 104-fixed ear; 201-native valve leaflet; 202-tendon cord; 301- Left atrium; 302-left ventricle; 401-sheath; 402-fixed head.
发明实施例  Invention Example
本发明的实施方式  Embodiments of the invention
[0041] 为了使本发明的创作特征、 技术手段与达成目的易于明白理解, 以下结合具体 实施例进一步阐述本发明。  [0041] In order to make the creative features, technical means and achievements of the present invention easy to understand, the following further describes the present invention in conjunction with specific embodiments.
[0042] 如图 1-2所示, 本发明提供了一种假体心脏瓣膜, 包括瓣膜支架 10, 固定于所 述瓣膜支架 10上的瓣叶 20, 以及附着在瓣膜支架 10内表面或外表面的裙边 30。 本发明实施例瓣膜支架 10主要是用于承载瓣叶、 裙边等结构的支撑定位件。  [0042] As shown in FIGS. 1-2, the present invention provides a prosthetic heart valve, including a valve support 10, a valve leaflet 20 fixed on the valve support 10, and attached to the inner surface or outer surface of the valve support 10 The surface skirt 30. The valve stent 10 of the embodiment of the present invention is mainly a support positioning member for supporting structures such as valve leaflets and skirts.
[0043] 优选地, 本发明实施例瓣膜支架 10采用金属材料制备而成。 优选地, 采用形状 记忆合金制造。 进一步地, 所述支架 10采用镍钛合金管材切割而成。 [0043] Preferably, the valve stent 10 of the embodiment of the present invention is made of a metal material. Preferably, it is made of shape memory alloy. Further, the bracket 10 is formed by cutting a nickel-titanium alloy pipe.
[0044] 优选地, 本发明实施例瓣叶 20为人工瓣叶, 是用于替代原生瓣膜瓣叶进行启闭 运动、 控制血流方向的部件。  [0044] Preferably, the valve leaflet 20 in the embodiment of the present invention is an artificial valve leaflet, which is a component used to replace the native valve leaflet for opening and closing movement and controlling the blood flow direction.
[0045] 优选地, 本发明实施例裙边 30由生物材料制备而成, 具体地, 可由聚对苯二甲 酸乙二醇酯 PET, 或聚四氟乙烯 PTFE, 或动物心包材料制作而成, 是具有防瓣 周漏等功能的一层薄膜。 [0046] 如图 3-4所示, 本发明实施例提供的瓣膜支架 10包括呈网格状设置的支架主体 1 02, 所述支架主体 102—端与至少一个抓耳 103固定连接, 另一端与法兰 101连接 。 具体实施中, 所述抓耳 103在瓣膜支架展开时用于抓取原生瓣叶, 所述法兰 10 1在所述瓣膜支架展开时用于紧贴左心房口和原生瓣叶。 [0045] Preferably, the skirt 30 of the embodiment of the present invention is made of biological material, specifically, it can be made of polyethylene terephthalate PET, or polytetrafluoroethylene PTFE, or animal pericardium material, It is a layer of film with functions such as anti-valvular leakage. [0046] As shown in FIGS. 3-4, a valve stent 10 provided in an embodiment of the present invention includes a stent body 102 arranged in a grid, one end of the stent body 102 is fixedly connected to at least one grasping ear 103, and the other end Connected to flange 101. In a specific implementation, the grasping ear 103 is used to grasp a native valve leaflet when the valve stent is deployed, and the flange 101 is used to closely adhere to the left atrium opening and the native valve leaflet when the valve stent is deployed.
[0047] 具体实施中, 本发明实施例抓耳 103的底端固定于所述支架主体 102上, 顶端径 向外翘形成竖杆形状, 并周向均匀分布于支架主体 102的外表面。 优选地, 所述 抓耳 103通过铆接、 或焊接、 或卡扣等方式固定于所述支架主体 102上。  [0047] In a specific implementation, the bottom end of the grip ear 103 of the embodiment of the present invention is fixed to the bracket body 102, and the top end is outwardly bent to form a vertical rod shape, and is evenly distributed on the outer surface of the bracket body 102 in the circumferential direction. Preferably, the grabbing ear 103 is fixed to the bracket body 102 by riveting, welding, or snapping.
[0048] 本发明实施例抓耳 103与支架主体 102的相对位置并不唯一。 支架主体 102靠近 法兰 101的一端为上端, 支架主体 102远离法兰 101的一端为下端, 支架主体 102 的下端网格即为支架主体 102的最底端网格。 优选地, 抓耳 103可位于支架主体 1 02的下端网格上, 以便于抓耳 103在抓取原生瓣叶 201的同时更好地钩挂腱索 202 , 形成下限位。 抓耳 103也可位于支架主体 102的其余各排网格上。 实施中, 抓 耳 103的具体位置可依据实际心脏解剖形态和支架主体 102的结构设计进行适当 调整。  [0048] The relative position of the gripping ear 103 and the bracket body 102 in the embodiment of the present invention is not unique. The end of the bracket body 102 near the flange 101 is the upper end, and the end of the bracket body 102 away from the flange 101 is the lower end. The lower grid of the bracket body 102 is the bottommost grid of the bracket body 102. Preferably, the grasping ear 103 may be located on the lower end grid of the stent body 102, so that the grasping ear 103 better grasps the tendon 202 while grasping the native valve leaflet 201 to form a lower limit. The gripping ears 103 can also be located on the remaining rows of grids of the bracket body 102. During implementation, the specific position of the grasping ear 103 can be adjusted appropriately according to the actual heart anatomy and the structural design of the stent body 102.
[0049] 进一步地, 本发明实施例抓耳 103的个数不固定, 优选地, 设置 6个抓耳 103, 实施中, 各抓耳 103可位于支架主体 102的同一排网格上, 也可交替位于支架主 体 102的不同排网格上, 可与支架主体 102的网格节点相连, 也可与支架主体 102 的网格边缘杆相连。 此处所述的一排网格指的是沿所述支架主体 102的周向排列 的一组网格。  [0049] Further, the number of grasping ears 103 in the embodiment of the present invention is not fixed, preferably, six grasping ears 103 are provided, and in implementation, each grasping ear 103 may be located on the same row of grids of the bracket body 102, or They are alternately located on different rows of grids of the bracket body 102, and can be connected to the grid nodes of the bracket body 102, and can also be connected to the grid edge bars of the bracket body 102. The row of grids described herein refers to a group of grids arranged along the circumference of the bracket body 102.
[0050] 优选地, 本发明实施例抓耳 103的整体大小小于与抓耳 103相连的支架主体 102 的网格的大小, 使得在瓣膜支架压握收缩进输送导管时, 抓耳 103可嵌入到与其 相连的支架主体 102的网格空间中, 以减小瓣膜支架在压握缩径后的支架厚度, 有利于瓣膜支架经股静脉路径介入人体, 从而减小输送器导管直径, 降低输送 难度和对血管的损伤。 与此相对应, 与抓耳 103相连的网格只能内表面缝合裙边 , 而不能外表面缝合裙边, 否则缝合外裙边会导致抓耳 103无法嵌入到该相连网 格中。  [0050] Preferably, the overall size of the grasping ear 103 of the embodiment of the present invention is smaller than the size of the mesh of the stent body 102 connected to the grasping ear 103, so that when the valve stent is compressed and contracted into the delivery catheter, the grasping ear 103 can be embedded into In the mesh space of the stent body 102 connected to it, to reduce the thickness of the stent after the compression and reduction of the diameter of the valve stent, it is helpful for the valve stent to intervene in the human body through the femoral vein path, thereby reducing the diameter of the conveyor catheter and reducing the difficulty of delivery and Damage to blood vessels. Corresponding to this, the mesh connected to the gripping ear 103 can only sew the skirt on the inner surface, but cannot sew the skirt on the outer surface. Otherwise, stitching the outer skirt will prevent the gripping ear 103 from being embedded in the connected mesh.
[0051] 优选地, 本发明实施例抓耳 103的形态多种多样, 可为直杆 (如图 8所示) , 也 可为略微弯曲的波杆 (如图 9所示) , 以增加抓耳 103对原生瓣叶的抓取力, 以 及提高其对腱索的钩挂性能。 但以上抓耳 103的所有形态均需满足“支架在压握收 缩进输送导管时, 抓耳 103可以嵌入到与之相连的网格中”的要求。 本发明实施例 抓耳 103的表面可设置为光滑表面, 也可以设置为粗糙表面。 优选地, 抓耳 103 上设有纹路结构, 纹路结构可以设置为规则纹路结构, 也可以设置为不规则纹 路结构, 以增加抓耳与瓣叶、 腱索之间的摩擦力。 [0051] Preferably, the grip ear 103 of the embodiment of the present invention has various shapes, which may be a straight rod (as shown in FIG. 8) or a slightly curved wave rod (as shown in FIG. 9) to increase the grip The grasping force of the ear 103 on the native leaflet, to And improve its hooking performance to tendon. However, all of the above shapes of the grasping ear 103 need to meet the requirement that “the grasping ear 103 can be embedded in the mesh connected to it when the stent is compressed and contracted into the delivery catheter. The surface of the gripping ear 103 in this embodiment of the present invention may be a smooth surface or a rough surface. Preferably, the grasping ear 103 is provided with a texture structure. The texture structure may be set as a regular texture structure or an irregular texture structure to increase the friction between the grasping ear and the valve leaflets and tendon cords.
[0052] 如图 11-12所示, 实施中, 心脏原生瓣叶循环重复着启闭运动, 抓耳 103抓取正 在进行闭合运动的原生瓣叶 201游离端, 此时, 由于抓耳 103的抓取限制, 原生 瓣叶 201将无法进行开启运动, 原生瓣叶 201紧密贴合在支架主体 102外表面, 达 到密封作用, 防止了瓣周漏的发生。 本发明实施例抓耳 103在抓取原生瓣叶 201 的同时, 钩挂腱索 202, 形成下限位 (参见图 12-C位置处) , 防止了瓣膜支架受 血流冲刷、 心脏挤压等外力而向左心房端脱出。 基于上述抓耳 103的固定和密封 机理, 本发明实施例不需要像部分传统支架那样通过大尺寸设计来获得支撑, 从而确保了支架主体 102较小直径的实现。  [0052] As shown in FIGS. 11-12, during the implementation, the cardiac native leaflet cycle repeats the opening and closing movement, and the grasping ear 103 grabs the free end of the native valve leaflet 201 that is undergoing the closing movement. At this time, due to the grasping ear 103 ’s Due to the gripping limitation, the native valve leaf 201 will not be able to perform the opening movement, and the native valve leaf 201 closely adheres to the outer surface of the stent body 102 to achieve the sealing effect and prevent the occurrence of paravalvular leakage. The grasping ear 103 of the embodiment of the present invention grabs the native valve leaf 201 and hooks the tendon 202 to form a lower limit (see the position of FIG. 12-C), which prevents the valve support from being washed by blood flow, squeezing the heart and other external forces And prolapse to the left atrium. Based on the above-mentioned fixing and sealing mechanism of the gripping ear 103, the embodiments of the present invention do not require large-scale design to obtain support like some conventional brackets, thereby ensuring the realization of a smaller diameter of the bracket body 102.
[0053] 优选地, 本发明实施例支架主体 102直径较小, 其上、 下端直径的范围为 20mm -50mm 可选的, 本发明支架主体 102可做成上下端直径相同的圆柱形, 也可做 成支架主体 102轮廓呈上宽下窄的倒梯形或上窄下宽的梯形, 甚至上下端同直径 中部外凸的水桶形等各种形状。 实施中, 优选下端较窄的形状, 因为在保证人 工瓣膜支架正常工作的情况下, 瓣膜支架下端越窄, 对主动脉的干涉越小。  [0053] Preferably, the stent body 102 of the embodiment of the present invention has a small diameter, and the upper and lower ends have a diameter ranging from 20mm to 50mm. Optionally, the stent body 102 of the present invention can be made into a cylindrical shape with the same diameter at the upper and lower ends. The bracket body 102 is formed in an inverted trapezoid shape with an upper width and a narrow width or a trapezoid shape with an upper width and a lower width, or even a bucket shape with a convex middle portion with the same diameter at the upper and lower ends. In implementation, a shape with a narrower lower end is preferred, because under the condition of ensuring the normal operation of the artificial valve stent, the narrower the lower end of the valve stent, the less the interference with the aorta.
[0054] 实施中, 根据不同的设计和使用需求, 本发明实施例可以在支架主体 102的内 表面或外表面或双面通过缝合、 粘连等手段附着裙边 30 同时, 支架主体 102内 部也通过缝合、 粘连等方式承载人工瓣叶。  [0054] In the implementation, according to different design and use requirements, the embodiments of the present invention may attach the skirt 30 to the inner surface or the outer surface or both sides of the stent body 102 by means of stitching, adhesion, etc. At the same time, the interior of the stent body 102 also passes Sutures, adhesions, etc. carry artificial leaflets.
[0055] 优选地, 本发明实施例支架主体 102的形式和形状多种多样, 除图示表现的直 筒圆柱形外, 支架主体 102轮廓还可根据心脏解剖结构更改为梯形、 倒梯形等适 合的形态。 而支架主体 102的网格形状也可为圆形、 菱形等各种适合的形状, 网 格的形状和大小可以均一, 也可以不均一。  [0055] Preferably, the form and shape of the stent body 102 in the embodiments of the present invention are various. In addition to the straight cylindrical shape shown in the figure, the contour of the stent body 102 can be changed to a trapezoid, an inverted trapezoid, etc. according to the heart anatomy. form. The grid shape of the bracket body 102 may also be various suitable shapes such as a circle and a diamond shape. The shape and size of the grid may be uniform or non-uniform.
[0056] 本发明实施例在保证支架主体 102功能正常完整的情况下, 可以通过材料、 工 艺、 结构等各种形式实现支架主体 102的柔软设置。  [0056] In the embodiment of the present invention, when the function of the stent body 102 is ensured to be normal and complete, the flexible setting of the stent body 102 can be achieved through various forms such as materials, processes, and structures.
[0057] 本发明实施中, 当瓣膜支架植入后, 支架主体 102周向与心脏原生瓣叶精密贴 合, 起到密封的作用。 支架主体 102直径较小, 瓣叶进行启闭运动所需的空间便 小, 相应地, 人工瓣叶的面积减小, 提高了瓣膜支架的耐疲劳性能。 [0057] In the implementation of the present invention, after the valve stent is implanted, the stent body 102 is precisely attached to the native heart valve leaflet in the circumferential direction Close, play a sealing role. The diameter of the stent body 102 is small, and the space required for the leaflet to perform the opening and closing movement is small. Accordingly, the area of the artificial leaflet is reduced, and the fatigue resistance of the valve stent is improved.
[0058] 实施中, 本发明实施例在不影响心脏正常功能的情况下, 支架主体 102上端部 分在左心房端伸出适当高度, 可将部分人工瓣叶开合所需的高度分摊到左心房 端, 进而减小瓣下高度, 亦可减轻瓣膜支架对主动脉瓣的影响, 降低了左心室 流出道阻塞的风险。  [0058] In the implementation, the embodiment of the present invention does not affect the normal function of the heart, the upper end portion of the stent body 102 at the left atrium end protrudes an appropriate height, can be part of the artificial valve leaf opening and closing height required to distribute to the left atrium End, thereby reducing the height of the subvalvular, can also reduce the impact of the valve stent on the aortic valve, and reduce the risk of left ventricular outflow tract obstruction.
[0059] 进一步地, 本发明实施例法兰 101的外径 D大于所述法兰 101与所述支架主体 102 连接处的直径 d, 使得法兰 101下水平面紧贴合心脏原生瓣环和瓣叶, 边缘上翘 端面紧贴左心房内壁, 起到上限位和密封的作用, 防止瓣膜支架向左心室端滑 出。  [0059] Further, in the embodiment of the present invention, the outer diameter D of the flange 101 is larger than the diameter d of the connection between the flange 101 and the stent body 102, so that the flange 101 is tightly attached to the heart annulus and valve The leaf, the edge upturned end surface is close to the inner wall of the left atrium, and serves as an upper limit and a seal to prevent the valve stent from sliding out to the left ventricular end.
[0060] 优选地, 本发明法兰 101边缘处的外径 D为法兰的最大直径, 30mm<D<80mm ; 所述法兰 101与所述支架主体 102相配合的连接处的直径 d为法兰 101的最小直 径, 20mmSd<50mm。  [0060] Preferably, the outer diameter D at the edge of the flange 101 of the present invention is the maximum diameter of the flange, 30mm <D <80mm; the diameter d of the connection between the flange 101 and the bracket body 102 is The minimum diameter of the flange 101 is 20mmSd <50mm.
[0061] 实施中, 法兰 101的最小直径 支架主体 102上端处的直径。 本发明实施例法兰 [0061] In practice, the minimum diameter of the flange 101 is the diameter at the upper end of the bracket body 102. The flange of the embodiment of the invention
101与支架主体 102在连接处的直径不一定相等, 如果不相等, 可将裙边、 心包 等连接物填充在这两者间隙之中。 根据不同的设计和使用需求, 本发明也可通 过缝合、 粘连等手段在法兰 101的内表面或外表面或双面附着裙边 30。 The diameter of the connection between 101 and the main body 102 of the stent is not necessarily equal. If they are not equal, you can fill the gap between the two by connecting the skirt, pericardium and other connecting objects. According to different design and usage requirements, the present invention can also attach the skirt 30 to the inner surface or outer surface of the flange 101 or both sides by means of stitching, adhesion and the like.
[0062] 优选地, 本发明实施例法兰 101连接在所述支架主体 102的设定高度位置。 如图 7所示, 本发明实施例支架主体 102上端可适当越过法兰 101下平面, 即法兰 101 与支架主体 102的连接点并非一定是端部, 法兰 101也可连接在支架主体 102的任 意适合的高度位置, 即瓣膜支架植入心脏后, 支架主体 102有部分露于左心房中 , 降低了瓣膜支架露于左心室中的瓣下高度, 减少了瓣膜支架对主动脉射血的 影响。 与此同时, 本发明实施例还可通过优化结构设计等手段保证支架主体 102 和法兰 101在压握缩径时, 连接处的波杆不会互相交叠而增加压握后的瓣膜支架 厚度。  [0062] Preferably, the flange 101 of the embodiment of the present invention is connected to the set height position of the bracket body 102. As shown in FIG. 7, the upper end of the bracket body 102 in the embodiment of the present invention can properly cross the lower plane of the flange 101, that is, the connection point between the flange 101 and the bracket body 102 is not necessarily an end, and the flange 101 can also be connected to the bracket body 102 Any suitable height position, that is, after the valve stent is implanted into the heart, the stent body 102 is partially exposed in the left atrium, which reduces the height of the valve stent below the left ventricle and reduces the valve stent's ejection of the aorta influences. At the same time, the embodiments of the present invention can also ensure that the stent body 102 and the flange 101 do not overlap with each other when the diameter of the stent body 102 and the flange 101 are compressed by the means such as optimized structural design, which increases the thickness of the valve stent after the crush .
[0063] 优选地, 本发明法兰 101由柔性材料制造。 本发明实施例在保证法兰 101功能正 常完整的情况下, 可以通过材料、 工艺、 结构等各种形式实现法兰 101的柔软设 置, 以保证宽大的法兰可被压握收缩进鞘管中, 进行后续的经股静脉路径介入 [0064] 本发明实施中, 瓣膜支架植入后, 抓耳 103在抓取瓣叶和钩挂腱索时, 会受到 原生组织朝向左心室的作用力, 因抓耳 103与支架主体 102连接, 导致整个支架 1 0都会受到该作用力的影响, 而具有朝向左心室移动的趋势, 此时法兰 101因反 作用力, 下水平面紧贴合心脏原生瓣环和瓣叶 (参见图 13-A位置处) , 边缘上 翘端面紧贴左心房内壁 (参见图 13-B位置处) , 起到上限位和密封的作用, 防 止瓣膜支架 10向左心室端滑出。 本发明法兰 101较为宽大, 可增强瓣膜支架 10在 左心房的密封性能, 更利于防止瓣周漏的发生。 [0063] Preferably, the flange 101 of the present invention is made of a flexible material. In the embodiment of the present invention, under the condition that the function of the flange 101 is normal and complete, the flexible setting of the flange 101 can be achieved through various forms of materials, processes, structures, etc., to ensure that the wide flange can be compressed and shrunk into the sheath , For follow-up transfemoral vein intervention [0064] In the implementation of the present invention, after the valve stent is implanted, the grasping ear 103 will be subjected to the force of the native tissue toward the left ventricle when grasping the valve leaflet and hooking the tendon, because the grasping ear 103 is connected to the stent body 102, As a result, the entire stent 10 will be affected by this force and tend to move toward the left ventricle. At this time, due to the reaction force, the flange 101 closely fits the native annulus and leaflet of the heart (see Figure 13-A At the end), the edge upturned end surface is closely attached to the inner wall of the left atrium (see position in Figure 13-B), which acts as an upper limit and seals to prevent the valve stent 10 from sliding out to the left ventricular end. The flange 101 of the present invention is relatively wide, which can enhance the sealing performance of the valve stent 10 in the left atrium, and is more conducive to preventing the occurrence of paravalvular leakage.
[0065] 由上, 本发明实施例支架的定位、 锚固和密封依靠法兰 101上限位、 抓耳 103下 限位和抓耳 103抓取瓣叶实现, 而部分传统支架是依靠大尺寸(Oversize)设计从而 获得径向支撑力支撑在原生瓣处, 支架所需的结构刚度较强。 所以, 相比之下 , 本发明实施例中支架的柔软设置, 更有利于瓣膜支架经股静脉路径介入人体 , 且瓣膜支架可被压握得更小, 适配的输送器导管直径更小, 降低了输送难度 和对血管的损伤。 进一步地, 本发明实施例法兰 101的制作方式多种多样, 本发 明提供了以下几种制作方式:  [0065] From the above, the positioning, anchoring and sealing of the stent according to the embodiment of the present invention is achieved by the upper limit of the flange 101, the lower limit of the grasping ear 103, and the grasping of the leaflet by the grasping ear 103, while some traditional stents rely on oversize It is designed to obtain the radial support force to be supported at the native petal, and the structural rigidity required by the stent is strong. Therefore, in contrast, the flexible arrangement of the stent in the embodiment of the present invention is more advantageous for the valve stent to intervene in the human body through the femoral vein path, and the valve stent can be compressed and held smaller, and the diameter of the adapted delivery catheter is smaller. Reduced the difficulty of delivery and damage to blood vessels. Further, there are various manufacturing methods of the flange 101 in the embodiment of the present invention, and the present invention provides the following manufacturing methods:
[0066] 一、 法兰 101与支架主体 102—体切割制作而成, 具体地, 通过激光切割金属管 材, 例如镍钛合金管材, 将法兰 101和支架主体 102同时切割出支架雏形, 再通 过热处理扩径定性工艺制成最终形态。  [0066] 1. The flange 101 and the bracket body 102 are produced by cutting together. Specifically, the metal tube, such as a nickel-titanium alloy pipe, is cut by laser, and the flange 101 and the bracket body 102 are simultaneously cut into the bracket prototype, and then passed The heat treatment diameter expansion qualitative process is made into the final form.
[0067] 二、 法兰 101与支架主体 102分体切割制作而成, 具体地, 通过激光切割金属管 材, 例如镍钛合金管材, 将法兰 101和支架主体 102分开切割出支架雏形, 再分 别通过热处理扩径定性工艺制成各自的最终形态, 最后再将法兰 101和支架主体 102连接成一体。  [0067] Second, the flange 101 and the bracket body 102 are separately cut and manufactured. Specifically, the metal tube, such as a nickel-titanium alloy tube, is cut by laser to separate the flange 101 and the bracket body 102 into a prototype bracket, and then separately The final shape is made by the heat treatment diameter expansion qualitative process, and finally the flange 101 and the bracket body 102 are connected into one body.
[0068] 需要说明的是, 法兰 101的制作方式并不仅局限于上述方式, 其他能够制作法 兰 101的方式均适用于本发明实施例。  [0068] It should be noted that the manufacturing method of the flange 101 is not limited to the above method, and other methods that can make the flange 101 are applicable to the embodiments of the present invention.
[0069] 优选地, 以上两种制作方式中的“激光切割金属管材”还可替换为“镍钛金属丝 编织”、 “3D打印”等各种适合的方式。  [0069] Preferably, the “laser cut metal pipe” in the above two production methods can also be replaced with various suitable methods such as “nickel-titanium wire braiding”, “3D printing” and the like.
[0070] 优选地, 本发明实施例法兰 101的形状多种多样, 除图示所示的网格结构外, 法兰 101轮廓还可设计为发散杆状、 发散树枝状等形式。 若法兰 101设计为网格 状, 网格的形式可为圆形、 菱形等各种适合的图形 (如图 5-6所示) , 网格的形 状和大小可以均一, 也可以不均一。 各杆、 环之间可相互连接, 亦可相互独立 [0070] Preferably, the shape of the flange 101 of the embodiment of the present invention is diverse, in addition to the grid structure shown in the figure, the outline of the flange 101 can also be designed in the form of divergent rods, divergent branches and the like. If the flange 101 is designed as a grid The shape of the grid can be various suitable shapes such as circles and diamonds (as shown in Figure 5-6). The shape and size of the grid can be uniform or non-uniform. The rods and rings can be connected to each other or independent of each other
[0071] 优选地, 本发明法兰 101与支架主体 102的连接方式包括但不限于以下一种或多 种: 绳线缝合、 裙边连接、 铆接或焊接。 [0071] Preferably, the connection method of the flange 101 of the present invention and the bracket body 102 includes, but is not limited to, one or more of the following: rope sewing, skirt connection, riveting or welding.
[0072] 进一步地, 本发明抓耳 103的制作方式也不唯一, 例如, 通过激光切割管材, 将抓耳 103与支架主体 102同时切割出支架雏形, 即在需要设置抓耳 103的网格间 隙中额外切割出一根杆, 再通过热处理扩径定性等工艺制成最终形态。 当然, 也可将抓耳 103与支架主体 102分体切割, 再通过铆接、 焊接、 卡扣等其他适合 的方式将抓耳 103与支架主体 102连接, 但不管何种工艺, 均需满足“支架在压握 收缩进输送导管时, 抓耳 103可以嵌入到与之相连的网格中”的要求, 如图 10所示  [0072] Further, the manufacturing method of the gripping ear 103 of the present invention is not unique, for example, by cutting the pipe material by laser, the gripping ear 103 and the bracket body 102 are simultaneously cut out of the prototype of the bracket, that is, the grid gap of the gripping ear 103 needs to be provided In addition, an additional rod is cut out, and then the final shape is made by heat treatment, diameter expansion and qualitative processes. Of course, the gripping ear 103 and the bracket body 102 can also be cut separately, and then the gripping ear 103 and the bracket body 102 can be connected by riveting, welding, snapping, or other suitable methods, but no matter what process, all When crimping into the delivery catheter, the grasping ear 103 can be embedded in the mesh connected to it, as shown in Figure 10
[0073] 进一步地, 如图 3所示, 本发明实施例法兰 101的自由端部设置有至少一个固定 耳 104, 所述固定耳 104将所述支架与输送装置固定。 [0073] Further, as shown in FIG. 3, the free end of the flange 101 of the embodiment of the present invention is provided with at least one fixing ear 104, and the fixing ear 104 fixes the bracket and the delivery device.
[0074] 实施中, 支架在实际制造时, 可在法兰 101上翘端部额外设计一些固定耳 104, 该固定耳 104主要用于卡扣在输送装置中与之相匹配的结构上, 使支架可以受输 送装置的牵拉或推送。 优选地, 固定耳 104可为凸出的圆块、 方块, 也可为支架 杆上切割出的圆孔等各种适合的形态。 优选地, 固定耳 104的个数至少为 3个, 或者为 3的倍数, 可为 3、 6、 9不等。 需要说明的是, 本发明实施例固定耳 104也 可根据不同的输送装置结构, 设计在瓣膜支架的其余适合位置。  [0074] In the implementation, when the bracket is actually manufactured, some fixing ears 104 may be additionally designed on the upturned end of the flange 101, and the fixing ears 104 are mainly used for snapping on a structure matching it in the conveying device, so that The stent can be pulled or pushed by the delivery device. Preferably, the fixing ear 104 may be a protruding round block or a square, or may be a round hole cut in the support rod, and other suitable forms. Preferably, the number of the fixed ears 104 is at least 3, or a multiple of 3, which may be 3, 6, 9 and so on. It should be noted that the fixing ear 104 according to the embodiment of the present invention may also be designed at other suitable positions of the valve support according to different delivery device structures.
[0075] 由于三尖瓣作为右心脏的房室瓣, 其结构与二尖瓣相似, 也包含瓣叶、 瓣环、 腱索、 乳头肌。 因此本发明实施例替换原生二尖瓣的心脏瓣膜支架也可以应用 于代替原生三尖瓣, 根据原生瓣膜尺寸不同瓣膜支架尺寸也不同。  [0075] Since the tricuspid valve serves as the atrioventricular valve of the right heart, its structure is similar to the mitral valve, and also includes valve leaflets, annulus, chordae, and papillary muscles. Therefore, the heart valve stent replacing the native mitral valve in the embodiment of the present invention can also be used to replace the native tricuspid valve, and the valve stent size is different according to the native valve size.
[0076] 根据本发明的另一个方面, 提供了一种假体心脏瓣膜支架输送器, 包括包裹压 握瓣膜支架的鞘管 401以及固定支架 10的固定头 402。 优选地, 所述固定头 402上 的凹槽与支架 10的固定耳 104相匹配。  [0076] According to another aspect of the present invention, a prosthetic heart valve stent delivery device is provided, which includes a sheath 401 that wraps a compression valve stent and a fixed head 402 that fixes the stent 10. Preferably, the groove on the fixing head 402 matches the fixing ear 104 of the bracket 10.
[0077] 实施中, 本发明实施例瓣膜支架的装载是在体外冰水浴中进行的。 如图 14所示 , 将瓣膜支架在 5°C以下冰水中压握, 将固定耳 104卡扣固定在固定头 402的凹槽 中, 再通过装载工具等辅助手段, 控制输送器手柄, 将瓣膜支架逐步收缩到鞘 管 401当中。 装载后, 输送器穿过导丝, 沿股静脉到达病变的二尖瓣位置, 选择 合适的释放位置开始释放。 [0077] In practice, the loading of the valve stent in the embodiment of the present invention is performed in an extracorporeal ice water bath. As shown in Fig. 14, the valve holder is pressed and held in ice water below 5 ° C, and the fixing ear 104 is snapped and fixed in the groove of the fixing head 402 In this process, the auxiliary device, such as a loading tool, controls the handle of the conveyor to gradually retract the valve stent into the sheath 401. After loading, the conveyor passes through the guide wire, along the femoral vein to the position of the diseased mitral valve, and selects the appropriate release position to start the release.
[0078] 本发明实施例瓣膜支架释放过程包括以下几个阶段。  [0078] The valve stent release process of the embodiment of the present invention includes the following stages.
[0079] 第一阶段: 控制手柄后撤鞘管 401, 先释放出抓耳 103 , 再继续后撤鞘管 401, 释放出支架主体 102的一部分, 此时保证抓耳 103有足够的周向直径, 使抓耳 103 在心脏原生二尖瓣瓣叶闭合时可以穿过足够多的腱索, 抓取瓣叶。  [0079] The first stage: after the control handle is withdrawn, the sheath tube 401 is released, and the grasping ear 103 is released first, and then the sheath tube 401 is removed afterwards, and a part of the stent body 102 is released. , So that the grasping ear 103 can pass through enough tendons to grasp the valve leaflet when the native mitral valve leaflet of the heart is closed.
[0080] 第二阶段: 向下推送输送器, 调整抓耳 103角度, 抓取瓣叶, 钩挂腱索。  [0080] The second stage: push the conveyor downward, adjust the angle of the grasping ear 103, grasp the leaflets, and hook the tendon.
[0081] 第三阶段: 继续后撤鞘管 401, 调整瓣膜支架位置和深度, 调整法兰 101和心脏 原生瓣叶相对位置, 完全释放法兰 101, 撤出输送器, 瓣膜支架 10开始正常工作  [0081] The third stage: continue to withdraw the sheath tube 401, adjust the position and depth of the valve holder, adjust the relative position of the flange 101 and the native heart valve leaflet, completely release the flange 101, withdraw the conveyor, and the valve holder 10 begins to work normally
[0082] 综上, 本发明以单层支架为前提的小直径支架主体, 兼容了易于压握输送和减 轻瓣膜支架对主动脉瓣影响的双重优势。 本发明抓耳体积较小, 在压握时可利 用网格空间容纳抓耳, 减小了瓣膜支架在压握缩径后的支架厚度, 更有利于瓣 膜支架经股静脉路径介入人体, 减小输送器导管直径, 降低了输送难度和对血 管的损伤。 本发明支架主体上端可适当越过法兰下平面, 露于左心房中, 从而 减小了瓣下高度, 减轻了瓣下乳头肌干涉、 主动脉窦干涉、 左心室流出道阻塞 等影响。 [0082] In summary, the present invention is based on a single-layer stent as the premise of the small-diameter stent body, compatible with the dual advantages of easy compression delivery and reducing the impact of the valve stent on the aortic valve. The ear grab of the present invention has a small volume, and the grid space can be used to hold the ear during crimping, which reduces the thickness of the stent of the valve stent after crimping and shrinking, and is more conducive to the intervention of the valve stent through the femoral vein path. The diameter of the conveyor catheter reduces the difficulty of delivery and damage to blood vessels. The upper end of the stent body of the present invention can properly cross the lower plane of the flange and be exposed in the left atrium, thereby reducing the height of the subvalvular, mitigating the effects of papillary muscle intervention, aortic sinus interference, and left ventricular outflow tract obstruction.
[0083] 以上显示和描述了本发明的基本原理、 主要特征和本发明的优点。 本行业的技 术人员应该了解, 本发明不受上述实施例的限制, 上述实施例和说明书中描述 的只是说明本发明的原理, 在不脱离本发明精神和范围的前提下本发明还会有 各种变化和改进, 这些变化和改进都落入要求保护的本发明范围内。 本发明要 求保护范围由所附的权利要求书及其等同物界定。  [0083] The basic principles, main features and advantages of the present invention are shown and described above. Those skilled in the art should understand that the present invention is not limited by the above-mentioned embodiments. The above-mentioned embodiments and the description only describe the principles of the present invention, and the present invention will have various aspects without departing from the spirit and scope of the present invention. Variations and improvements that fall within the scope of the claimed invention. The scope of protection required by the present invention is defined by the appended claims and their equivalents.

Claims

权利要求书 Claims
[权利要求 1] 一种瓣膜支架, 其特征在于, 包括呈网格状设置的支架主体 (102) [Claim 1] A valve stent, characterized by comprising a stent body (102) arranged in a grid
、 与所述支架主体 (102) 连接的至少一个抓耳 (103) 和法兰 (101 ) , 所述法兰 (101) 的外径 D大于所述法兰 (101) 与所述支架主体 (102) 连接处的直径 d, 在瓣膜支架压缩入鞘时, 所述抓耳 (103) 嵌入与抓耳 (103) 相连的支架主体 (102) 的网格中。 , At least one grab ear (103) and flange (101) connected to the bracket body (102), the outer diameter D of the flange (101) is greater than the flange (101) and the bracket body ( 102) The diameter d of the connection, when the valve stent is compressed into the sheath, the grasping ear (103) is embedded in the grid of the stent body (102) connected to the grasping ear (103).
[权利要求 2] 根据权利要求 1所述的瓣膜支架, 其特征在于, 所述支架主体 (102) 的上端或下端的直径的范围为 20mm-50mm。  [Claim 2] The valve stent according to claim 1, characterized in that the diameter of the upper or lower end of the stent body (102) ranges from 20 mm to 50 mm.
[权利要求 3] 根据权利要求 1所述的瓣膜支架, 其特征在于, 所述法兰 (101) 的外 径的范围为 30mm^D^80mm。  [Claim 3] The valve stent according to claim 1, characterized in that the outer diameter of the flange (101) is in the range of 30 mm ^ D ^ 80 mm.
[权利要求 4] 根据权利要求 3所述的瓣膜支架, 其特征在于, 所述法兰 (101) 与所 述支架主体 (102) 连接处的直径的范围为 20mm^d^50mm。 [Claim 4] The valve stent according to claim 3, characterized in that the diameter of the connection between the flange (101) and the stent body (102) is 20 mm ^ d ^ 50 mm.
[权利要求 5] 根据权利要求 1-4任一所述的瓣膜支架, 其特征在于, 所述抓耳 (103 ) 的一端固定于支架主体 (102) 上, 另一端径向外翘。 [Claim 5] The valve stent according to any one of claims 1-4, characterized in that one end of the grasping ear (103) is fixed to the stent body (102), and the other end is radially outwardly warped.
[权利要求 6] 根据权利要求 5所述的瓣膜支架, 其特征在于, 所述抓耳 (103) 为直 杆或弯曲的波杆。 [Claim 6] The valve stent according to claim 5, characterized in that the grasping ear (103) is a straight rod or a curved wave rod.
[权利要求 7] 根据权利要求 6所述的瓣膜支架, 其特征在于, 所述抓耳 (103) 上设 有纹路结构。 [Claim 7] The valve stent according to claim 6, characterized in that a texture structure is provided on the grasping ear (103).
[权利要求 8] 根据权利要求 1所述的瓣膜支架, 其特征在于, 所述抓耳 (103) 与所 述支架主体 (102) 的网格节点相连, 或与所述支架主体 (102) 的网 格边缘杆相连。 [Claim 8] The valve stent according to claim 1, characterized in that the grasping ear (103) is connected to a grid node of the stent body (102), or is connected to a mesh node of the stent body (102) The grid edge bars are connected.
[权利要求 9] 根据权利要求 1所述的瓣膜支架, 其特征在于, 所述抓耳 (103) 位于 所述支架主体 (102) 的下端网格上。  [Claim 9] The valve stent according to claim 1, characterized in that the grasping ear (103) is located on the lower end grid of the stent body (102).
[权利要求 10] 根据权利要求 1所述的瓣膜支架, 其特征在于, 所述法兰 (101) 的自 由端部设置有至少一个固定耳 (104) , 所述固定耳 (104) 用于与输 送装置的凹槽相配合。  [Claim 10] The valve support according to claim 1, characterized in that at least one fixing ear (104) is provided at the free end of the flange (101), and the fixing ear (104) is used for The grooves of the conveyor match.
[权利要求 11] 根据权利要求 10所述的瓣膜支架, 其特征在于, 所述固定耳 (104) 为凸出的圆块或方块。 [Claim 11] The valve stent according to claim 10, wherein the fixing ear (104) is a convex round block or square.
[权利要求 12] 根据权利要求 1所述的瓣膜支架, 其特征在于, 所述法兰 (101) 连接 在所述支架主体 (102) 的设定高度位置。 [Claim 12] The valve stent according to claim 1, wherein the flange (101) is connected to a set height position of the stent body (102).
[权利要求 13] 根据权利要求 1所述的瓣膜支架, 其特征在于, 所述网格的形状为圆 形或菱形。  [Claim 13] The valve stent according to claim 1, wherein the shape of the mesh is a circle or a diamond.
[权利要求 14] 一种假体心脏瓣膜, 其特征在于, 包括权利要求 1-13任一所述的瓣膜 支架, 还包括固定于所述瓣膜支架上的瓣叶 (20) , 以及附着在瓣膜 支架内表面或外表面的裙边 (30) 。  [Claim 14] A prosthetic heart valve, characterized by comprising the valve support according to any one of claims 1-13, further comprising a valve leaflet (20) fixed on the valve support, and attached to the valve Skirt (30) on the inner or outer surface of the bracket.
[权利要求 15] 根据权利要求 14所述的假体心脏瓣膜, 其特征在于, 与所述抓耳 (10  [Claim 15] The prosthetic heart valve according to claim 14, characterized in that, with the grasping ear (10
3) 相连的所述支架主体 (102) 的网格在内表面上设置所述裙边。  3) The grid of the connected bracket body (102) sets the skirt on the inner surface.
PCT/CN2019/110538 2018-10-11 2019-10-11 Valve stent and prosthetic heart valve WO2020073981A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811181564.4 2018-10-11
CN201811181564.4A CN111035472A (en) 2018-10-11 2018-10-11 Valve support and prosthetic heart valve

Publications (1)

Publication Number Publication Date
WO2020073981A1 true WO2020073981A1 (en) 2020-04-16

Family

ID=70163601

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/110538 WO2020073981A1 (en) 2018-10-11 2019-10-11 Valve stent and prosthetic heart valve

Country Status (2)

Country Link
CN (1) CN111035472A (en)
WO (1) WO2020073981A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111714250A (en) * 2019-03-22 2020-09-29 上海微创心通医疗科技有限公司 Heart valve support and prosthesis thereof
WO2022012010A1 (en) * 2020-07-15 2022-01-20 上海臻亿医疗科技有限公司 Heart valve prosthesis
CN113332000B (en) * 2021-07-12 2024-04-26 上海臻亿医疗科技有限公司 Bracket loading system and method
CN113855333A (en) * 2021-10-18 2021-12-31 上海欣吉特生物科技有限公司 Split type valve support reaches intervention mitral valve replacement system including it
CN114028030B (en) * 2021-11-09 2023-02-28 上海臻亿医疗科技有限公司 Artificial heart valve

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140194975A1 (en) * 2013-01-08 2014-07-10 Medtronic CV Luxembourg S.a.r.l. Method of Treating Paravalvular Leakage After Prosthetic Valve Implantation
CN104302247A (en) * 2011-11-23 2015-01-21 内奥瓦斯克迪亚拉公司 Sequentially deployed transcatheter mitral valve prosthesis
CN106264793A (en) * 2016-10-24 2017-01-04 宁波健世生物科技有限公司 A kind of adaptive heart valve prosthesis
CN108463188A (en) * 2017-01-11 2018-08-28 米塔埃瑟斯医疗有限公司 Multilayer cardiac implant
CN207804429U (en) * 2017-06-09 2018-09-04 上海微创心通医疗科技有限公司 Mitral valve prosthese, tricuspid valve prosthese and its holder

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104302247A (en) * 2011-11-23 2015-01-21 内奥瓦斯克迪亚拉公司 Sequentially deployed transcatheter mitral valve prosthesis
US20140194975A1 (en) * 2013-01-08 2014-07-10 Medtronic CV Luxembourg S.a.r.l. Method of Treating Paravalvular Leakage After Prosthetic Valve Implantation
CN106264793A (en) * 2016-10-24 2017-01-04 宁波健世生物科技有限公司 A kind of adaptive heart valve prosthesis
CN108463188A (en) * 2017-01-11 2018-08-28 米塔埃瑟斯医疗有限公司 Multilayer cardiac implant
CN207804429U (en) * 2017-06-09 2018-09-04 上海微创心通医疗科技有限公司 Mitral valve prosthese, tricuspid valve prosthese and its holder

Also Published As

Publication number Publication date
CN111035472A (en) 2020-04-21

Similar Documents

Publication Publication Date Title
WO2020073981A1 (en) Valve stent and prosthetic heart valve
US10543079B2 (en) Heart valve prosthesis
CN209122540U (en) A kind of valve bracket and prosthetic heart valve
CN108135696B (en) Heart valve prosthesis
JP2019506937A (en) Heart valve prosthesis and method with multiple support arms for percutaneous heart valve replacement
US11395735B2 (en) Valve stent and valve prosthesis
CN111110398A (en) Split type heart valve support and prosthesis thereof
CN105125322B (en) A kind of new artificial valve&#39;s prosthese
WO2014127750A1 (en) Heart valve prosthesis
WO2023082579A1 (en) Artificial heart valve
CN111714250A (en) Heart valve support and prosthesis thereof
CN111110403A (en) Heart valve device with anchoring ring and using method thereof
WO2019128583A1 (en) Cardiac valve prosthesis and stent thereof
CN111265334B (en) Separated movable support and intervention type artificial heart prosthesis valve
CN111265332B (en) Artificial heart prosthesis valve
CN111265333B (en) Telescopic movable support and intervention type artificial heart prosthesis valve
CN212382790U (en) Heart valve device with anchoring ring
CN113440308A (en) Valve prosthesis with variable positioning part and conveying system thereof
CN217138356U (en) Artificial heart valve and conveying system and replacement system thereof
CN111249036B (en) Artificial heart prosthesis valve with movable support
CN212853731U (en) Heart stent and heart valve prosthesis
CN210301307U (en) Heart valve support and prosthesis thereof
WO2022077794A1 (en) Implantable prosthetic valve device and implantation method therefor
CN111904664A (en) Tricuspid valve prosthesis
WO2022267210A1 (en) Artificial heart valve and delivery system therefor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19870707

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19870707

Country of ref document: EP

Kind code of ref document: A1